Cargando…
Septic shock-3 vs 2: an analysis of the ALBIOS study
BACKGROUND: A reanalysis of the ALBIOS trial suggested that patients with septic shock - defined by vasopressor-dependent hypotension in the presence of severe sepsis (Shock-2) - had a survival benefit when treated with albumin. The new septic shock definition (Shock-3) added the criterion of a lact...
Autores principales: | Vasques, Francesco, Duscio, Eleonora, Romitti, Federica, Pasticci, Iacopo, Caironi, Pietro, Meessen, Jennifer, Latini, Roberto, Cressoni, Massimo, Camporota, Luigi, Pesenti, Antonio, Fumagalli, Roberto, Quintel, Michael, Gattinoni, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161337/ https://www.ncbi.nlm.nih.gov/pubmed/30261898 http://dx.doi.org/10.1186/s13054-018-2169-8 |
Ejemplares similares
-
Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS
por: Piotti, Arianna, et al.
Publicado: (2021) -
Compared values of presepsin (sCD14-ST) and procalcitonin as early markers of outcome in severe sepsis and septic shock: a preliminary report from the Albumin Italian Outcome Sepsis (ALBIOS) study
por: Caironi, P, et al.
Publicado: (2013) -
Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief
por: Caironi, Pietro, et al.
Publicado: (2014) -
Extracorporeal gas exchange: when to start and how to end?
por: Gattinoni, L., et al.
Publicado: (2019) -
Albumin Oxidation Status in Sepsis Patients Treated With Albumin or Crystalloids
por: Bonifazi, Matteo, et al.
Publicado: (2021)